Ostocal

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ostocal

Ostocal is a foundational combination product used to supplement essential micronutrients, primarily Calcium Carbonate and Cholecalciferol (Vitamin D3). Its general purpose is to support key structural and metabolic processes that rely on these components.


Quick Facts

Property Description
Active ingredient Calcium Carbonate, Cholecalciferol (Vitamin D3)
Form Oral Tablet (including chewable and film-coated variants)
Pharmacological class Mineral and Vitamin supplement, Specific mineral preparation
Common use Maintaining systemic Calcium balance and bone support
Origin Derived, incorporating inorganic salt and vitamin derivative

What Type of Supplement is Ostocal?

Ostocal is classified as a Mineral and Vitamin supplement, placing it within the therapeutic group of Specific mineral preparations. Its identity is established by the simultaneous inclusion of two essential active components: Calcium Carbonate and Cholecalciferol. The importance of this combination is recognized for its supportive role in nutritional therapy. Calcium and Vitamin D3 preparations are considered essential components for the supportive treatment of bone health conditions, confirming their global relevance. This preparation is positioned for use across various patient groups, including the elderly and pregnant women, where increased mineral intake is often a requirement.

Core Composition and Pharmaceutical Form

The composition relies on Calcium Carbonate to deliver the crucial Elemental Calcium, complemented by Cholecalciferol (Vitamin D3), necessary for effective absorption. Vitamin D is essential for the body to properly absorb and use calcium from the digestive tract. This particular product is differentiated by its available Tablet dosage form(s), specifically offering Chewable Tablet variants. These variants are designed for individuals who require an easier, non-film-coated mode of Oral administration. The formulation ensures consistent, high-purity mineral delivery, meeting official pharmacopoeial standards.

General Purpose and Physiological Role

The overall goal of Ostocal is to maintain systemic Calcium balance and support the structural integrity of the skeletal system. This is achieved through the Absorption Enhancement mechanism, driven by Cholecalciferol, ensuring the Calcium Carbonate is efficiently utilized by the body. A typical scenario involves its use by pregnant women to prevent Calcium depletion required for fetal skeletal development. This dual action provides essential support to help prevent chronic mineral deficits, thereby contributing to overall physiological function and stability.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Ostocal?

Official Adverse Reactions and Safety Profile

The safety profile for Ostocal, a combination of Calcium Carbonate and Cholecalciferol (Vitamin D3), is defined by classifications set forth in government regulatory documents. The primary focus of documented adverse reactions involves Metabolism and Nutrition Disorders and the Gastrointestinal system.

Frequency-Classified Effects

Adverse reactions are classified by frequency as follows:

  • Uncommon (affecting up to 1 in 100 people): Hypercalcaemia (high calcium levels in the blood) and Hypercalciuria (high calcium levels in the urine).
  • Rare (affecting up to 1 in 1,000 people): Gastrointestinal disturbances such as Constipation, Flatulence, Nausea, Abdominal pain, and Diarrhoea. Skin reactions, including Rash and Urticaria (hives), are also classified as rare.
  • Not Known (cannot be estimated from available data): Severe Hypersensitivity reactions, which include conditions such as angioedema.

Serious Adverse Reactions and Restrictions

Specific serious adverse reactions documented in regulatory sources include Milk-alkali syndrome (Burnett's Syndrome), which is typically associated with high-dose, long-term use. Extreme or prolonged Hypercalcaemia is also a serious concern, as it has been documented to lead to severe outcomes like cardiac arrhythmias and irreversible renal damage.

Use of Ostocal is officially contraindicated in individuals with pre-existing conditions of calcium overload, specifically Hypercalcaemia, Hypercalciuria, Hypervitaminosis D, or conditions like Nephrolithiasis (kidney stones). Safety notes also emphasize the need for caution in patients with renal impairment, as there is a documented risk of soft tissue calcification, which requires monitoring of calcium levels.

Overdose and Emergency Response

Overdose and when to seek help

An overdose of Ostocal (Calcium Carbonate and Cholecalciferol) is officially characterized by the physiological conditions of hypercalcaemia and hypervitaminosis D, as documented in government regulatory sources.

Documented Overdose Manifestations

Overdose presentation may include general signs of hypercalcaemia such as nausea, vomiting, constipation, and anorexia. More systematic clinical manifestations involve fatigue, muscle weakness, excessive thirst (polydipsia), and increased urination (polyuria). Neurological signs such as confusion, mental disturbances, and headache are also documented. Severe laboratory findings include elevated serum calcium (hypercalcaemia) and elevated urinary calcium (hypercalciuria).

Severe Outcomes and Emergency Action

Severe or chronic overdose carries the risk of Systemic Organ Toxicity. Documented serious outcomes include cardiac arrhythmias, nephrocalcinosis, nephrolithiasis, and potentially irreversible renal damage or acute renal failure. Due to these life-threatening consequences, the regulatory mandate is to seek immediate medical attention for any suspected overdose. The first necessary step is the discontinuation of Ostocal and any concomitant treatments that may exacerbate the hypercalcaemic state. No specific antidote is known.

Management and Special Considerations

Official management is supportive and symptomatic, focusing on lowering serum calcium levels through rehydration and fluid replacement. Monitoring of serum calcium levels, renal function, and electrocardiogram (ECG) is often required. Patients with impaired renal function are at increased risk of severe toxicity and require special consideration.

Therapeutic Uses of Ostocal

What Ostocal Treats: Main Uses and Benefits

The core therapeutic meaning of Ostocal—a combination of Calcium Carbonate and Cholecalciferol (Vitamin D3)—is commonly used in conditions presenting with systemic or localized discomfort related to mineral deficits. Official guidance indicates that adequate calcium and Vitamin D intake is relevant for maintaining bone strength and may assist with lowering the risk of developing osteoporosis or rickets.


Ostocal is applied across domains where additional symptomatic support is needed, playing a role in managing conditions characterized by structural compromise such as osteomalacia and Hypoparathyroidism. It also addresses symptoms related to systemic imbalance, including involuntary muscle cramps and spasms—symptoms of increased neurological or muscular activity. The product is also commonly used to provide symptomatic assistance for gastrointestinal hyperacidity, helping to ease heartburn and acid indigestion. This is relevant across multiple therapeutic domains, assisting with maintaining functional stability.

The medication is commonly applied during periods of heightened physiological demand in patient groups such as pregnant and lactating women, and is a relevant therapeutic adjunct for postmenopausal women and individuals with certain chronic states like Chronic Renal Failure, supporting general well-being during symptomatic phases.

Focus: Symptomatic Domains
Skeletal Support: Helps manage conditions characterized by structural compromise and chronic mineral deficits.
Gastrointestinal: Offers symptomatic assistance when needed for heartburn and dyspepsia.
Neuromuscular: Helps address symptoms of increased neurological or muscular activity, such as muscle cramps and twitching.

Regulatory References

  1. MedlinePlus Medical Encyclopedia on Calcium and Vitamin D

Eligibility and Restrictions for Use

Who Can and Cannot Use Ostocal?

Eligibility for Ostocal, a combination of Calcium Carbonate and Cholecalciferol (Vitamin D3), is strictly defined by regulatory documents based on pre-existing mineral status and certain health conditions.

Classification Official Regulatory Statement
Populations Contraindicated (Must Not Use) Individuals with high calcium levels in the blood (Hypercalcaemia) or urine (Hypercalciuria). Use is also prohibited in cases of Hypervitaminosis D (Vitamin D toxicity) and in patients with a history of Nephrolithiasis (kidney stones) or known hypersensitivity to the ingredients.
Populations Allowed Adults and the Elderly. Use is also permitted for Pregnant and Lactating Women, provided the total daily intake of calcium and vitamin D remains within established safe upper limits.
Age-Related Rules Use of high-dose formulations is often Not Recommended or Contraindicated in the Pediatric population (children and adolescents).
Conditional Use Restrictions Patients with Severe Renal Impairment are typically Not Recommended to use the cholecalciferol form. Use in patients with Sarcoidosis or Immobilization Osteoporosis requires extreme caution and monitoring of calcium levels due to increased risk.

What should I know about interactions with other medicines?

Ostocal's interaction profile is primarily defined by the properties of its two active components, Calcium Carbonate and Cholecalciferol (Vitamin D3). Documented interactions require careful consideration and may involve mandatory restrictions or specific administrative rules.

The calcium component can cause Chelation and Reduced Systemic Exposure of co-administered medicines. Regulatory documents state that this interaction occurs with certain drug classes, including Quinolone and Tetracycline antibiotics, Bisphosphonates, and Levothyroxine (thyroid hormone). To mitigate the reduced absorption of these co-administered drugs, Mandatory Administration Separation is required, often ranging from 30 minutes to 2 hours.

Ostocal is formally Contraindicated in combination with Pharmacologic Doses of Vitamin D and other Vitamin D Analogs due to the risk of Pharmacodynamic Additive Effects, which can lead to hypercalcemia. This additive risk extends to other substances, such as Cardiac Glycosides, where excess calcium can potentiate their action and exacerbate heart rhythm concerns. Furthermore, the absorption of Ostocal's Vitamin D3 component can be reduced by agents like Bile Acid Sequestrants. Officially documented Food and Substance Interactions include Phytic acid- and Oxalic acid-rich foods, which can impair calcium absorption. Caution is also noted for administration in patients with renal impairment.

Mechanism of Action

Modulating Systemic Calcium Homeostasis

This domain involves the active regulation of calcium levels in the plasma, an essential electrolyte. The elemental calcium component of Ostocal dissociates to provide Ca^2+ ions, directly influencing key signaling cascades. This increases the available calcium pool for crucial biological processes like neuromuscular excitability, cardiac function, and blood coagulation, influencing feedback loops that modulate pathway activity.


️ Regulating Intestinal and Renal Ion Transport

This mechanism focuses on Vitamin D's role as a prohormone. Vitamin D3 is converted to its active metabolite, calcitriol, which acts as a Vitamin D Receptor (VDR) agonist—a key pathway effect. This action significantly enhances the absorption of dietary calcium from the gastrointestinal tract and promotes the reabsorption of calcium in the kidneys. This results in a net increase in systemic calcium retention, which provides substrate for calcium-dependent structural components.

Dosage and Administration Information

How to Use Ostocal

Ostocal (Calcium Carbonate and Cholecalciferol) is administered exclusively via the oral route, available in forms such as chewable and film-coated tablets. The administration pattern covers both the quantity and timing of intake.

For long-term supplementation and adjunct therapy in bone health, the typical regimen is defined by the elemental strength, generally resulting in a total daily dose of 500 mg to 1500 mg of elemental Calcium. This amount is usually administered in a once daily or twice daily frequency.

Instructions specify that the medication should be taken with food or immediately following a meal to enhance the absorption of the mineral and vitamin components. Specific procedural rules apply to certain forms: chewable tablets must be chewed or sucked completely prior to swallowing. If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped entirely, avoiding dose doubling.

A critical instruction involves time separation from other prescribed treatments; the medicine must be taken at least three hours before or four to six hours after taking certain interacting medications, such as specific antibiotics or bisphosphonates, to prevent reduced effectiveness. Furthermore, use is restricted in cases of severe renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ostocal

Evidence for use in Skeletal Health Maintenance

Research has extensively examined the combination of Calcium Carbonate and Cholecalciferol (Vitamin D3) in studies exploring outcomes related to systemic or functional imbalance, particularly in skeletal health. These research efforts primarily include Randomized Controlled Trials (RCTs) and larger observational settings. Researchers have monitored outcomes related to systemic or functional imbalance, specifically focusing on measurements of Bone Mineral Density ( BMD) measurements at key skeletal sites, and tracking the incidence of fractures in the observed populations.

The studies focused mainly on populations like postmenopausal women and older adults. Findings were mixed across studies regarding fracture incidence, often depending on the specific group being observed in the trials, such as whether participants started the study with low Vitamin D levels. The certainty regarding the consistency of results is not uniform; the evidence is often considered heterogeneous.

Evidence for use during Heightened Physiological Demand

The combination was evaluated in research exploring short-term physiological changes during periods of increased symptom activity. Studies included women who were pregnant, sometimes focusing on those with specific nutritional deficits. These trials monitored maternal outcomes related to systemic or functional imbalance, including measurements of calcium and Vitamin D levels in the blood, and tracked the frequency of certain events like pre-eclampsia and gestational hypertension.

Long-term effects are not fully established for infant outcomes, as follow-up durations were limited in most maternal supplementation research. Also, research exploring short-term symptom changes related to episodes where symptoms become more noticeable is often based on limited, smaller trials.

Research on Temporary Gastrointestinal Uses

The Calcium Carbonate component of Ostocal was studied for its application in conditions characterized by episodic or acute manifestations, such as heartburn and indigestion. This research primarily focused on Pharmacodynamic studies, which means they observe the immediate action of the product in the body. These studies examined outcomes related to physical discomfort, primarily by tracking the change in the stomach's pH level. The follow-up durations were limited, typically lasting only hours or a few days, providing limited information on long-term outcomes for chronic use.

What is Still Uncertain about Ostocal

A key area of ongoing research is the overall consistency of findings related to long-term fracture risk reduction across all groups. Comparative evidence is lacking for many potential uses, which means there is limited research comparing the combination to single-ingredient supplements. Research is ongoing to better understand how the two components were observed in relation to each other and to clarify the impact in various populations.

Key Studies & References

  1. Calcium Carbonate - StatPearls - NCBI Bookshelf (Antacid Pharmacodynamics)
  2. Vitamin D: MedlinePlus Medical Encyclopedia (General Vitamin D/Calcium Context)
  3. Colecalciferol - eEML - Electronic Essential Medicines List (WHO Regulatory Context)

Frequently Asked Questions (FAQ)

Common questions about Ostocal (FAQ)

Q: Is Ostocal considered a vitamin supplement or a prescription drug?

A: Official classifications for products containing Calcium Carbonate and Cholecalciferol can differ based on the strength of the ingredients and the intended use. While the product is generally classified as a mineral and vitamin supplement, some specific strengths or indications are designated by regulatory bodies as prescription medicines, while others may be available Over-The-Counter (OTC).


Q: How does Ostocal compare to other bone-health products?

A: Official documents summarizing research evidence typically focus on the effects of this combination product versus an inactive substance (placebo). Regulatory summaries generally do not provide direct comparisons of the drug combination to many other bone-health products or single-ingredient supplements.


Q: Why do official documents state Ostocal is for certain uses but people use it for other things?

A: Regulatory documents define the approved uses of the drug, which are specific conditions like preventing or treating low blood calcium and bone loss conditions. The calcium component alone has also been studied for other, temporary uses such as acid indigestion. It is important to know that official indications are limited to the specific conditions approved by health authorities.


Q: Can I take Ostocal with my blood pressure medicine?

A: Official information indicates that caution is necessary if this medicine is used alongside certain cardiovascular medications, including drugs like cardiac glycosides (which affect heart rhythm) and some diuretics. Regulatory warnings mention that the use of this product alongside certain heart medicines may require calcium levels to be monitored.


Q: Are there any studies about Ostocal's effect on muscle function?

A: The elemental calcium component is physiologically necessary for key body processes, including neuromuscular excitability, which involves communication between the nerves and muscles. While clinical trials primarily focus on bone health, the fundamental role of calcium in muscle function is established in pharmacological descriptions.


Q: Why is Vitamin D included in the Ostocal formulation?

A: Vitamin D3 (cholecalciferol) is included in the formulation because it plays a fundamental role in calcium metabolism. According to official pharmacological descriptions, Vitamin D acts to increase the amount of calcium your body can absorb from the food you eat in the digestive system and help the body retain necessary calcium levels.


Q: Does Ostocal interfere with the absorption of iron supplements?

A: Yes, regulatory information indicates that if iron supplements are needed at the same time as this medication, they should be taken at different times. Regulatory documents indicate a need to separate the administration time from iron supplements to minimize potential interference with the absorption of iron.


Q: What is the official definition of the condition Ostocal is approved to treat?

A: Regulatory bodies have approved the combination product for the prevention and treatment of calcium and vitamin D deficiencies. It is also indicated for use as an adjunct to specific therapy for conditions involving bone loss, such as osteoporosis.


Q: Does Ostocal help with joint pain or only bone strength?

A: Clinical trials and evidence summaries for the drug focus on outcomes related to the skeleton, specifically bone mineral density (BMD) and the incidence of fractures. Official documents do not typically address the treatment of joint pain as a studied outcome or stated indication for this product.


Q: Are there any specific warnings for people with thyroid conditions taking Ostocal?

A: Official drug interaction warnings advise caution for those taking Levothyroxine, which is used to treat thyroid conditions. The calcium component can interact, and official guidance notes that separation of administration time, typically by at least four hours, is documented to help prevent reduced absorption of the thyroid medicine.


Q: Are there long-term safety data available for Ostocal?

A: Safety warnings mention that the serious reaction known as Milk-alkali syndrome is typically associated with high-dose, long-term use. Additionally, official documents state that elevated calcium levels (hypercalcaemia) have been observed during prolonged treatment with high dosages.


Q: What happens if I forget to take Ostocal with food?

A: The official instructions specify taking the medication with food or immediately after a meal to optimize the absorption of the mineral and vitamin components. The instructions advise taking the product with food as this is intended to help ensure the proper absorption of the mineral and vitamin components.


Q: Does Ostocal contain any common allergens like lactose or gluten?

A: Information regarding the product's inactive ingredients (excipients) is available in official documents, and formulations may contain substances like sorbitol or sucrose. Contraindications for allergies, such as to soya oil or peanuts, are listed in regulatory warnings for some specific products.


Q: What should be done if a dose of Ostocal is missed?

A: Regulatory guidance advises that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely. Guidance states that dose doubling should be avoided.


Q: Is Ostocal safe for people with a history of digestive disorders?

A: Regulatory documents list a caution for people who have difficulty absorbing nutrition from food (malabsorption syndrome), as this can affect how the drug works. Furthermore, official documentation lists contraindications for use in certain gastrointestinal conditions such as Zollinger-Ellison syndrome, and common side effects include constipation and abdominal pain.


Q: Can I take Ostocal if I am also taking an antacid?

A: The official information advises caution when taking this medication alongside other antacids, particularly those containing aluminum or magnesium. Concurrent use may lead to potential absorption problems or, in some patients, elevated magnesium levels. Regulatory documents state that this combination may necessitate careful monitoring.


Q: Do lifestyle factors like smoking affect how well Ostocal works?

A: Official and authoritative sources note that certain lifestyle factors, such as smoking, can influence the body's metabolism of calcium and vitamin D. These factors can potentially affect the absorption of the supplement. Official information indicates that certain lifestyle factors may warrant discussion with a healthcare provider.


Q: What is the storage requirement for Ostocal tablets?

A: Official regulatory requirements advise that the tablets must be stored at room temperature. Regulatory instructions define that the container should be kept tightly closed to protect the product from light and moisture, and should be stored out of the sight and reach of children.

How should Ostocal be stored and disposed of?

Storage Requirements

Ostocal (Calcium Carbonate and Cholecalciferol) must be stored at room temperature in a cool, dry place, consistent with its official labeling. The medication container must be kept tightly closed to protect the product from light and moisture, which is necessary to maintain its stability up to the labeled expiry date.

Regulatory warnings require the product to be kept out of the sight and reach of children.

Disposal Instructions

Official disposal guidance instructs users to follow any specific instructions printed on the product's label. If no drug take-back program is available, the FDA recommends removing the product from its container, mixing it with an undesirable substance (such as used coffee grounds), and placing the mixture in a sealed bag or container before disposing of it in household trash. Users must scratch out all identifying information on the label before discarding the container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ostocal found in:

A-Z Index: